Monoclonal Antibodies: A New Horizon for Cancer Treatment

References

• Houghton AN, Scheinberg DA: Monoclonal antibodies: potential applications to the treatment of cancer. Semin Oncol 13 (2): 165–179, 1986.
   Web of Science ®Google Scholar
• Old LJ: Cancer immunology: the search for specificity—G.H.A. Clowes Memorial lecture. Cancer Res 41: 361–375, 1981.
   PubMed Web of Science ®Google Scholar
• Kohler G, Milstein C: Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256: 495–497, 1975.
   PubMed Web of Science ®Google Scholar
• Reisfeld RA, Cheresh DA: Human tumor antigens. Adv Immunol 40: 323–377, 1987.
   PubMed Web of Science ®Google Scholar
• Foon KA, Todd RF: Immunologic classification of leukemia and lymphoma. Blood 68: 1–31, 1986.
   PubMed Web of Science ®Google Scholar
• Sikora K, Smedley H: Monoclonal antibodies. In: Hancock BW, Ward AM, eds: Immunological Aspects of Cancer. Boston, Martinus Nijhoff Netherlands, 1985, pp 163–177.
   Google Scholar
• Nilsson O, Brezicka FT, Holmgren J, et al: Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. Cancer Res 46: 1403–1407, 1986.
   PubMed Web of Science ®Google Scholar
• Gatter KC, Alcock C, Heryet A, et al: Clinical importance of analysing malignant tumors of uncertain origin with immunohistochemical techniques. Lancet 1: 1302–1305, 1985.
   PubMed Web of Science ®Google Scholar
• Tong AW, Lee JC, Stone MJ: Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies. JNCI 77: 1023–1033, 1986.
   Google Scholar
• Larson SM: Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med 26: 538–545, 1985.
   PubMed Web of Science ®Google Scholar
• Foon KA, Schroff RW, Bunn PA, et al: Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. Blood 64: 1085–1093, 1984.
   PubMed Web of Science ®Google Scholar
• Dillman RO, Shawler DL, Dillman JB, et al: Monoclonal antibody in patients with chronic lymphocytic leukemia and cutaneous T cell lymphoma. J Cell Biochem (suppl) 9A: 108, 1985.
   Google Scholar
• Bertram JH, Gill PS, Levine AM, et al: Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. Blood 68: 752–761, 1986.
   PubMed Web of Science ®Google Scholar
• Levy R, Miller RA, Stratte PT, et al: Therapeutic trials of monoclonal antibody in leukemia and lymphoma: biologic considerations. In: Boss BD, Langman R, Trowbridge I, et al, eds: Monoclonal Antibodies and Cancer. Orlando, FL, Academic Press, 1983, pp 5–16.
   Google Scholar
• Shawler DL, Miceli MC, Wormsley SB, et al: Induction of in vitro and in vivo antigenic modulation by the anti-human T cell monoclonal antibody T101. Cancer Res 44: 5921–5927, 1984.
   Web of Science ®Google Scholar
• Miller RA, Maloney DG, Warnke R, et al: Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 306: 517–522, 1982.
   PubMed Web of Science ®Google Scholar
• Rankin EM, Hekman A, Somers R, et al: Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies. Blood 65: 1373–1381, 1985.
   PubMed Web of Science ®Google Scholar
• Lowder JN, Meeker TC, Campbell M, et al: Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood 69: 199–210, 1987.
   PubMed Web of Science ®Google Scholar
• Press OW, Appelbaum F, Ledbetter JA, et al: Monoclonal antibody IF5 (anti-CD 20) serotherapy of human B cell lymphomas. Blood 69: 584–591, 1987.
   PubMed Web of Science ®Google Scholar
• Ritz J, Pesando JM, Sallan SE, et al: Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58: 141–152, 1981.
   PubMed Web of Science ®Google Scholar
• Ball ED, Bernier GM, Cornwell GG, et al: Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. Blood 62: 1203–1210, 1983.
   PubMed Web of Science ®Google Scholar
• Sears HF, Herlyn D, Steplewski Z, et al: Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J Biol Response Mod 3 (2): 138–150, 1984.
   Google Scholar
• Sears HF, Herlyn D, Steplewski Z, et al: Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma. Cancer Res 45: 5910–5913, 1985.
   PubMed Web of Science ®Google Scholar
• Goodman GE, Beaumier P, Hellstrom I, et al: Pilot trial of murine monoclonal antibodies in patients with advanced melanoma. J Clin Oncol 3: 340–352, 1985.
   PubMed Web of Science ®Google Scholar
• Oldham RK, Foon KA, Morgan AC, et al: Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration. J Clin Oncol 2: 1235–1244, 1984.
   PubMed Web of Science ®Google Scholar
• Houghton AN, Mintzer D, Cordon-Cardo C, et al: Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci 82: 1242–1246, 1985.
   PubMed Web of Science ®Google Scholar
• Schroff RW, Foon KA, Beatty SM, et al: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45: 870–885, 1985.
   Web of Science ®Google Scholar
• Vitetta ES, Fulton RJ, May RD, et al: Redesigning nature's poisons to create anti-tumor reagents. Science 238: 1098–1104, 1987.
   PubMed Web of Science ®Google Scholar
• Baldwin RW, Byers VS: Monoclonal antibodies in cancer treatment. Lancet 1: 603–605, 1986.
   Web of Science ®Google Scholar
• Treleaven JG, Kemshead JT: Removal of tumor cells from bone marrow: an evaluation of the available techniques. Hematol Oncol 3: 65–75, 1985.
   PubMed Web of Science ®Google Scholar
• Badger CC, Bernstein ID: Prospects for monoclonal antibody therapy of leukemia and lymphoma. Cancer 58: 584–589, 1986.
   Google Scholar
• Tong AW, Lee JC, Fay JW, et al: Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement. Blood 70: 1482–1489, 1987.
   PubMed Web of Science ®Google Scholar
• Hamblin JL: Monoclonal antibodies: in vivo or in vitro. Plasma Ther Transfus Technol 7: 437–442, 1986.
   Google Scholar
• French D, Fischberg E, Buhl S, et al: The production of more useful monoclonal antibodies. 1. Modifications of the basic technology. Immunol Today 7: 344–346, 1986.
   Google Scholar
• Aguila HL, Pollock RR, Spira G, et al: The production of more useful monoclonal antibodies. 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies. Immunol Today 7: 380–383, 1986.
   Google Scholar
• Pinsky CM: Monoclonal antibodies: progress is slow but sure (editorial). N Engl J Med 315: 704–705, 1986.
   Web of Science ®Google Scholar